Select Page

  GRI Report

Since 2009 Biogen has conducted biennial materiality assessments informed by the Global Reporting Initiative (GRI) Principles for Defining Report Content to identify and prioritize the corporate responsibility topics and issues most important to the company and its stakeholders.

GRI Data Table

GRI Index

Independent Assurance Statement to Biogen Inc.

GRI Report

Since 2009 Biogen has conducted biennial materiality assessments informed by the Global Reporting Initiative (GRI) Principles for Defining Report Content to identify and prioritize the corporate responsibility topics and issues most important to the company and its stakeholders.

GRI Data Table

GRI Index

Independent Assurance Statement to Biogen Inc.

About the Report

The 2017 Corporate Citizenship Report contains data from calendar year 2017. In some instances, we include information on initiatives or activities that may have begun in 2017, but have continued into 2018.

This report was prepared in accordance with the GRI G4 Guidelines “core” option. Please refer to the GRI Index to see which material aspects and relevant indicators are reported. Also, see below for how we track our efforts in alignment with the United Nations’ Sustainable Development Goals (SDGs).

Data in this report covers our worldwide operations, including consolidated subsidiaries but excluding joint ventures. Our operations in 2017 encompassed our four major facilities in North Carolina, Denmark and Cambridge, Massachusetts. The boundaries also include our global offices and our commercial fleet operations. With regard to environmental data presented in this report, the scope includes operations in which we have operational control.

ERM Certification and Verification Services, Inc. (ERM CVS) assured the 2017 data for a number of indicators including Scope 1, Scope 2 and Scope 3 GHG emissions; Biogen’s carbon neutrality methodology; and select environmental and social indicators. See the ERM CVS Assurance Statement for full details of the assurance scope, assurance standards used, work undertaken and conclusions.

GRI Materiality Assessment

We are using the 2016 GRI materiality assessment for the 2017 report, the most recent GRI materiality assessment available. In this assessment, we identified 18 issues for further attention.

After reviewing the entire list, a set of tier one priorities was agreed upon for immediate attention, including: access to treatments, investments in R&D to ensure a robust pipeline and improving patient outcomes. Throughout this 2017 Corporate Citizenship Report, we explain how Biogen is addressing these issues and measuring performance.

The process to develop the 2016 GRI materiality assessment involved external stakeholder interviews, desk research to establish the broader sustainability context, an internal visioning workshop to prioritize and validate the issues and external stakeholder meetings to review the findings and gather feedback. We intend to conduct a new GRI materiality assessment for the 2018 Corporate Citizenship Report.

GRI Materiality Assessment Process

Supporting the SDGs

Biogen is committed to the United Nations’ SDGs. The SDGs comprise 17 goals and 169 associated targets that incorporate the economic, social and environmental dimensions of sustainable development. At Biogen, we support all 17 goals and encourage all businesses to consider how they may also contribute. We continue to refine our strategy to align with the SDGs that are most relevant to our business:

Our Commitments & Policies

Our commitments are grounded in our Values in Action – Code of Business Conduct, the Biogen Sustainability Policy and other related policies and position statements. These policies outline our focus on ethical business conduct, compliance, accountability and transparency, among other topics. To review the full list of our commitments and guiding principles, visit Our Guiding Principles.